Cabaletta Bio Inc. (CABA) NASDAQ

$11.56 0.10 (0.83%)

Market Cap: $324.68M

As of 11/30/21 10:04 AM EST. Market open.

(CABA)

Cabaletta Bio Inc. (CABA) NASDAQ

$11.56 0.10 (0.83%)

Market Cap: $324.68M

As of 11/30/21 10:04 AM EST. Market open.

Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. The Cabaletta Approach to selective B cell Ablation (CABA) platform, in combination with Cabaletta's proprietary technology, ... read more

Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. The Cabaletta Approach to selective B cell Ablation (CABA) platform, in combination with Cabaletta's proprietary technology, utilizes Chimeric AutoAntibody Receptor (CAAR) T cells that are designed to selectively bind and eliminate only specific autoantibody-producing B cells while sparing normal antibody-producing B cells, which are essential for human health. The Company's lead product candidate, DSG3-CAART, is being evaluated in the DesCAARTes™ phase 1 clinical trial as a potential treatment for patients with mucosal pemphigus vulgaris, a prototypical B cell-mediated autoimmune disease. The FDA granted Fast Track Designation for DSG3-CAART in May 2020. The Company's lead preclinical product candidate, MuSK-CAART, is in IND-enabling studies and is designed as a potential treatment for patients with MuSK-associated myasthenia gravis. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
34
Address
.
KEY STATS
Open
$11.56
Previous Close
$11.46
Days Range
$11.38 - $12.45
52 week range
$7 - $16.38
Volume
3,709
Avg. Volume (30 days)
180,237
Market Cap
$324.68M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
28,331,638
Open
$11.56
Previous Close
$11.46
Days Range
$11.38 - $12.45
52 week range
$7 - $16.38
Volume
3,709
Avg. Volume (30 days)
180,237
Market Cap
$324.68M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
28,331,638

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CABALETTA BIO INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
5AM Ventures V, L.P. 10% Owner Nov 01, 2021 Sale $13.00 295,000 3,835,000 1,731,119 Nov 03, 2021, 04:38 PM
5AM Ventures V, L.P. 10% Owner Sep 07, 2021 Sale $9.70 625,000 6,062,500 1,989,575 Sep 09, 2021, 05:34 PM
5AM Ventures V, L.P. 10% Owner Jan 12, 2021 Sale $13.00 85,000 1,105,000 2,614,575 Jan 12, 2021, 05:07 PM
5AM Ventures V, L.P. 10% Owner Jan 08, 2021 Sale $13.00 302,000 3,926,000 2,689,045 Jan 12, 2021, 05:07 PM
5AM Ventures V, L.P. 10% Owner Dec 10, 2020 Sale $14.75 298,000 4,395,500 2,953,634 Dec 14, 2020, 05:58 PM
5AM Ventures V, L.P. 10% Owner Oct 29, 2019 Buy $11.00 454,545 4,999,995 454,545 Oct 31, 2019, 06:03 PM
Flynn James E 10% Owner Oct 29, 2019 Buy $11.00 700,000 7,700,000 700,000 Oct 30, 2019, 06:04 PM
Buy Sale Option Exercise
Owner Relationship Date Value($)
5AM Ventures V, L.P. 10% Owner 11/01/2021 3,835,000
5AM Ventures V, L.P. 10% Owner 09/07/2021 6,062,500
5AM Ventures V, L.P. 10% Owner 01/12/2021 1,105,000
5AM Ventures V, L.P. 10% Owner 01/08/2021 3,926,000
5AM Ventures V, L.P. 10% Owner 12/10/2020 4,395,500
5AM Ventures V, L.P. 10% Owner 10/29/2019 4,999,995
Flynn James E 10% Owner 10/29/2019 7,700,000
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
13.45%
1Q
09/30/2021
03/31/2021
13.65%
2Q
09/30/2021
12/31/2020
17.74%
3Q
09/30/2021
09/30/2020
17.78%
4Q
09/30/2021
06/30/2020
17.88%
5Q
09/30/2021
03/31/2020
17.88%
6Q
09/30/2021
12/31/2019
17.88%
7Q
Load More

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
13.45%
1Q
03/31/2021
13.65%
2Q
12/31/2020
17.74%
3Q
09/30/2020
17.78%
4Q
06/30/2020
17.88%
5Q
03/31/2020
17.88%
6Q
12/31/2019
17.88%
7Q
Load More